Literature DB >> 11536216

Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS).

A D Edwards1, B Y Shekunov, A Kordikowski, R T Forbes, P York.   

Abstract

Pure anhydrous polymorphs of carbamazepine were prepared by solution-enhanced dispersion with supercritical fluids (SEDS). Crystallization of the polymorphs was studied. Mechanisms are proposed that consider the thermodynamics of carbamazepine, supersaturation in the SEDS process, and the binary phase equilibria of organic solvents and the carbon dioxide antisolvent. alpha-Carbamazepine was crystallized at high supersaturations and low temperatures, beta-carbamazepine crystallized from a methanol-carbon dioxide phase split, and gamma-carbamazepine crystallized via nucleation at high temperatures and low supersaturation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536216     DOI: 10.1002/jps.1065

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Self-built supercritical CO2 anti-solvent unit design, construction and operation using carbamazepine.

Authors:  Dan Meng; James Falconer; Karen Krauel-Goellner; John J J J Chen; Mohammed Farid; Raid G Alany
Journal:  AAPS PharmSciTech       Date:  2008-08-09       Impact factor: 3.246

2.  Influence of polymorphism on the surface energetics of salmeterol xinafoate crystallized from supercritical fluids.

Authors:  Henry H Y Tong; Boris Yu Shekunov; Peter York; Albert H L Chow
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

3.  In Situ Focused Beam Reflectance Measurement (FBRM), Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) and Raman Characterization of the Polymorphic Transformation of Carbamazepine.

Authors:  Yingying Zhao; Ying Bao; Jingkang Wang; Sohrab Rohani
Journal:  Pharmaceutics       Date:  2012-02-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.